(Q26778990)

English

Fluorouracil plasma monitoring: systematic review and economic evaluation of the My5-FU assay for guiding dose adjustment in patients receiving fluorouracil chemotherapy by continuous infusion

scientific article

In more languages

Statements

scholarly article

0 references

systematic review

1 reference

based on heuristic

inferred from title

Fluorouracil plasma monitoring: systematic review and economic evaluation of the My5-FU assay for guiding dose adjustment in patients receiving fluorouracil chemotherapy by continuous infusion (English)

0 references

0 references

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

8

0 references

Karoline Freeman

object named as

Karoline Freeman

1

0 references

object named as

Rachel Court

6

0 references

Sian Taylor-Phillips

object named as

Sian Taylor-Phillips

5

0 references

author name string

Martin Connock

2

0 references

Ewen Cummins

3

0 references

Tara Gurung

4

0 references

Mark Saunders

7

0 references

Paul Sutcliffe

9

0 references

language of work or name

0 references

publication date

November 2015

0 references

Health Technology Assessment

0 references

19

0 references

1-321, v-vi

0 references

91

0 references

Post-surgical chemotherapy versus surgery alone for resectable gastric cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent chemoradiotherapy with weekly versus three-weekly cisplatin in locally advanced head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

A new, validated HPLC-MS/MS method for the simultaneous determination of the anti-cancer agent capecitabine and its metabolites: 5'-deoxy-5-fluorocytidine, 5'-deoxy-5-fluorouridine, 5-fluorouracil and 5-fluorodihydrouracil, in human plasma

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

LC-MS/MS method for simultaneous analysis of uracil, 5,6-dihydrouracil, 5-fluorouracil and 5-fluoro-5,6-dihydrouracil in human plasma for therapeutic drug monitoring and toxicity prediction in cancer patients

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

The evolution of cancer of the colon and rectum

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost utility of docetaxel as induction chemotherapy followed by chemoradiation in locally advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan).

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

DoseVersus pharmacokinetics for predicting tolerance to 5-day continuous infusion of 5-FU

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Network meta-analysis of parametric survival curves

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival and recurrence free benefits with different lymphadenectomy for resectable gastric cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitation of 5-fluorouracil (5-FU) in human plasma by liquid chromatography/electrospray ionization tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life in survivors of colorectal carcinoma

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Nutrition and colorectal cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacokinetic study of 5-FU in continuous 5-day infusions for head and neck cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical significance of monitoring serum levels of 5-fluorouracil by continuous infusion in patients with advanced colonic cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of oxaliplatin on 5-fluorouracil plasma clearance and clinical consequences

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Individual 5-FU dose adaptation in metastatic colorectal cancer: results of a phase II study using a bimonthly pharmacokinetically intensified LV5FU2 regimen

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Health-related quality of life and colorectal cancer-specific symptoms in patients with chemotherapy-refractory metastatic disease treated with panitumumab

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensity of chemotherapy-induced emesis and overall survival as determinants of a global utility score.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

An analysis of the therapeutic efficacy of protracted infusion of low-dose 5-fluorouracil and cisplatin in advanced gastric cancer.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Chained time trade-off and standard gamble methods. Applications in oesophageal cancer.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Utility elicitation study in the UK general public for late-stage chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Preference weights for chemotherapy side effects from the perspective of women with breast cancer.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Health utility scores of colorectal cancer based on societal preference in Japan.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Preference values associated with stage III colon cancer and adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

A systematic review of utility values for chemotherapy-related adverse events.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

The costs of treating febrile neutropenia in six U.K. Hospitals

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Head and neck cancer in the south west of England, Hampshire, and the Isle of Wight: trends in survival 1996-2008.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology and risk factors for pancreatic cancer.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Body Surface Area–based Dosing of 5-Fluoruracil Results in Extensive Interindividual Variability in 5-Fluorouracil Exposure in Colorectal Cancer Patients on FOLFOX Regimens

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Individual fluorouracil dose adjustment in FOLFOX based on pharmacokinetic follow-up compared with conventional body-area-surface dosing: a phase II, proof-of-concept study

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Utility and work productivity data for economic evaluation of breast cancer therapies in the Netherlands and Sweden

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy dosing part II: alternative approaches and future prospects

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

The Quality-of-Life Impact of Head and Neck Cancer: Preference Values from the Canadian General Public

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Does cancer risk affect health-related quality of life in patients with Barrett's esophagus?

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Patients' perceived health status following primary surgery for oral and oropharyngeal cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Development and utilization of a combined LC-UV and LC-MS/MS method for the simultaneous analysis of tegafur and 5-fluorouracil in human plasma to support a phase I clinical study of oral UFT®/leucovorin

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Utility values in National Institute for Health and Clinical Excellence (NICE) Technology Appraisals

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness of granulocyte colony-stimulating factor prophylaxis for febrile neutropenia in breast cancer in the United Kingdom

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

The cost-effectiveness of different chemotherapy strategies for patients with poor prognosis advanced colorectal cancer (MRC FOCUS).

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness of cetuximab, cetuximab plus irinotecan, and panitumumab for third and further lines of treatment for KRAS wild-type patients with metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

The pathophysiology, clinical presentation, and diagnosis of colon cancer and adenomatous polyps.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

The cost-effectiveness of Foscan mediated photodynamic therapy (Foscan-PDT) compared with extensive palliative surgery and palliative chemotherapy for patients with advanced head and neck cancer in the UK.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Health State Utility Assessment for Breast Cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of quality of life-related utilities for health states relevant to ovarian cancer diagnosis and treatment

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic study of oxaliplatin iv chronomodulated infusion combined with 5-fluorouracil iv continuous infusion in the treatment of advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluating health utility in patients with melanoma, breast cancer, colon cancer, and lung cancer: a nationwide, population-based assessment

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Statistical methods for assessing agreement between two methods of clinical measurement

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life and utility in irradiated laryngeal cancer patients.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid and sensitive high-performance liquid chromatographic analysis of halogenopyrimidines in plasma

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Costs of conventional radical radiotherapy versus continuous hyperfractionated accelerated radiotherapy (CHART) in the treatment of patients with head and neck cancer or carcinoma of the bronchus. Medical Research Council CHART Steering Committee.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Capecitabine (Xeloda) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Deriving a compound quality of life measure from the EORTC-QLQ-C30/LC13 instrument for use in economic evaluations of lung cancer clinical trials.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Irinotecan in second-line treatment of metastatic colorectal cancer: improved survival and cost-effect compared with infusional 5-FU.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Highlights from: 5-Fluorouracil Drug Management Pharmacokinetics and Pharmacogenomics Workshop; Orlando, Florida; January 2007

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Validity of utilities of patients with esophageal cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

CONSOLIDATED HEALTH ECONOMIC EVALUATION REPORTING STANDARDS (CHEERS) STATEMENT

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

The "linked evidence approach" to assess medical tests: a critical analysis.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

The burden of Helicobacter pylori infection in England and Wales

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic and pharmacodynamic comparison of two doses of calcium folinate combined with continuous fluorouracil infusion in patients with advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between 5-fluorouracil disposition, toxicity and dihydropyrimidine dehydrogenase activity in cancer patients

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized controlled clinical trial of palliative therapies for patients with inoperable esophageal cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

5-FU therapeutic monitoring with dose adjustment leads to an improved therapeutic index in head and neck cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

A Q-TWiST analysis comparing panitumumab plus best supportive care (BSC) with BSC alone in patients with wild-type KRAS metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Health-related quality of life in patients with metastatic colorectal cancer treated with panitumumab in first- or second-line treatment

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Red and processed meat consumption and risk of pancreatic cancer: meta-analysis of prospective studies

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Spontaneous or imposed circadian changes in plasma concentrations of 5-fluorouracil coadministered with folinic acid and oxaliplatin: relationship with mucosal toxicity in patients with cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced pancreatic carcinoma: current treatment and future challenges

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and economic benefits of irinotecan in combination with 5-fluorouracil and folinic acid as first line treatment of metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Costs and consequences of different chemotherapy regimens in metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Health state utilities for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness analysis of cetuximab/irinotecan vs active/best supportive care for the treatment of metastatic colorectal cancer patients who have failed previous chemotherapy treatment

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Societal preference values for advanced melanoma health states in the United Kingdom and Australia

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

The influence of fluorouracil outcome parameters on tolerance and efficacy in patients with advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness in the management of patients with oesophageal cancer.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of socioeconomic deprivation on outcome after surgery for colorectal cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Are health states 'timeless'? A case study of an acute condition: post-chemotherapy nausea and vomiting.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

The annual cost of blood transfusions in the UK.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

5-fluorouracil steady state pharmacokinetics and outcome in patients receiving protracted venous infusion for advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

A Prospective Study of Family History and the Risk of Colorectal Cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Cetuximab for the treatment of colorectal cancer.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Individually tailored toxicity-based 5-fluorouracil, epirubicin and cyclophosphamide (FEC) therapy of metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

A pooled analysis of second primary pancreatic cancer.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparative economic analysis of pegylated liposomal doxorubicin versus topotecan in ovarian cancer in the USA and the UK.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology, management and economic impact of febrile neutropenia in oncology patients receiving routine care at a regional UK cancer centre

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trial.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetically guided dose adjustment of 5-fluorouracil: a rational approach to improving therapeutic outcomes

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Dietary risk factors for colon cancer in a low-risk population

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurement of plasma 5-fluorouracil by high-performance liquid chromatography with comparison of results to tissue drug levels observed using in vivo 19F magnetic resonance spectroscopy in patients on a protracted venous infusion with or without int

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Burden of disease due to cancer in England and Wales.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic resection for colorectal liver metastases: A cost-effectiveness analysis.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

A rapid and inexpensive method for anticipating severe toxicity to fluorouracil and fluorouracil-based chemotherapy

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I, pharmacokinetic, and bone marrow drug-level studies of tri-monthly 48-h infusion of high-dose 5-fluorouracil and leucovorin in patients with metastatic colorectal cancers

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus status and the risk of pancreatic cancer: a meta-analysis.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Preference-based utility scores for adverse events associated with the treatment of gynecologic cancers

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost comparisons and methodological heterogeneity in cost-of-illness studies: the example of colorectal cancer.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Health-related quality of life in colorectal cancer.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

A simple and rapid high-performance liquid chromatographic (HPLC) method for 5-fluorouracil (5-FU) assay in plasma and possible detection of patients with impaired dihydropyrimidine dehydrogenase (DPD) activity

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Health state utility scores for cancer-related anemia through societal and patient valuations

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of health state utilities and quality of life in patients with malignant esophageal Dysphagia

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Current concepts and novel targets in advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Pancreatic cancer: epidemiology and risk factors.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical impact of intesified 5-Fluorouracil-based chemotherapy using a prospective pharmacokinetically-guided dosing approach: comparative study in elderly and non-elderly patients with metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Laparoscopic supracervical hysterectomy compared with second-generation endometrial ablation for heavy menstrual bleeding: the HEALTH RCT

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved curve fits to summary survival data: application to economic evaluation of health technologies.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence and survival of oesophageal and gastric cancer in England between 1998 and 2007, a population-based study

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Health state utilities for non small cell lung cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Population preference values for treatment outcomes in chronic lymphocytic leukaemia: a cross-sectional utility study

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of adverse events and quality of life data for an economic evaluation of adjuvant chemotherapy in colorectal cancer: when can we stop collecting?

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Economic burden of resected squamous cell carcinoma of the head and neck in an incident cohort of patients in the UK.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Population study of dihydropyrimidine dehydrogenase in cancer patients

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between fluorouracil systemic exposure and tumor response and patient survival

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacodynamics of fluorouracil-based induction chemotherapy in advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term weekly treatment of colorectal metastatic cancer with fluorouracil and leucovorin: results of a multicentric prospective trial of fluorouracil dosage optimization by pharmacokinetic monitoring in 152 patients

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-utility analysis of chemotherapy using paclitaxel, docetaxel, or vinorelbine for patients with anthracycline-resistant breast cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation between uracil and dihydrouracil plasma ratio, fluorouracil (5-FU) pharmacokinetic parameters, and tolerance in patients with advanced colorectal cancer: A potential interest for predicting 5-FU toxicity and determining optimal 5-FU dosa

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III study of high-dose fluorouracil given as a weekly 24-hour infusion with or without leucovorin versus bolus fluorouracil plus leucovorin in advanced colorectal cancer: European organization of Research and Treatment of Cancer Gas

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of genetic and nongenetic factors for fluorouracil treatment-related severe toxicity: a prospective clinical trial by the German 5-FU Toxicity Study Group

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Docetaxel in combination with doxorubicin and cyclophosphamide as adjuvant treatment for early node-positive breast cancer: a cost-effectiveness and cost-utility analysis

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Individual fluorouracil dose adjustment based on pharmacokinetic follow-up compared with conventional dosage: results of a multicenter randomized trial of patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Defining the optimal treatment for clinical stage I nonseminomatous germ cell testicular cancer using decision analysis

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Stabilisation in colorectal cancer.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of age, sex and socioeconomic deprivation on outcomes in a colorectal cancer screening programme.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative evaluation of the My5-FU™ immunoassay and LC-MS/MS in monitoring the 5-fluorouracil plasma levels in cancer patients.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of plyometric training on swimming block start performance in adolescents

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter evaluation of a novel nanoparticle immunoassay for 5-fluorouracil on the Olympus AU400 analyzer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Modeling the 5-fluorouracil area under the curve versus dose relationship to develop a pharmacokinetic dosing algorithm for colorectal cancer patients receiving FOLFOX6.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

A community-based multicenter trial of pharmacokinetically guided 5-fluorouracil dosing for personalized colorectal cancer therapy

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

The costs of treating febrile neutropenia in patients with malignant blood disorders

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

A new decision model for cost-utility comparisons of chemotherapy in recurrent metastatic breast cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost effectiveness of amphotericin B plus G-CSF compared with amphotericin B monotherapy. Treatment of presumed deep-seated fungal infection in neutropenic patients in the UK.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost effectiveness of treatment options in advanced breast cancer in the UK.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant erythropoietin for chemotherapy-related anaemia: economic value and health-related quality-of-life assessment using direct utility elicitation and discrete choice experiment methods

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic adaptation of 5-fluorouracil: where are we and where are we going?

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Elicitation of health state utilities in neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemoprevention of colorectal cancer: systematic review and economic evaluation

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Global cancer statistics

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

TNM staging of cancers of the head and neck: striving for uniformity among diversity.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel strategies to improve the anticancer action of 5-fluorouracil by using drug delivery systems

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Personalizing colon cancer therapeutics: targeting old and new mechanisms of action.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness of systemic therapies for metastatic pancreatic cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant chemotherapy for gastric cancer: current evidence and future challenges.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Dihydropyrimidine dehydrogenase deficiency, a pharmacogenetic syndrome associated with potentially life-threatening toxicity following 5-fluorouracil administration

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Colorectal carcinoma: Pathologic aspects

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Preliminary observations indicate variable patterns of plasma 5-fluorouracil (5-FU) levels during dose optimization of infusional 5-FU in colorectal cancer patients.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

The molecular pathogenesis of head and neck cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Variability in fluorouracil exposure during continuous intravenous infusion

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

1 reference

https://api.crossref.org/works/10.3310%2FHTA19910

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.3310/HTA19910

0 references

0 references

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q26778990&oldid=1584671068"